Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
359.90
+2.63 (0.74%)
Oct 27, 2026, 9:13 AM EDT - Market open

CRL Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
1,004995.83994.231,0051,032984.171,0031,0101,0261,0121,0131,0271,0601,0291,100989.16973.13913.93905.05895.94
Revenue Growth (YoY)
-2.72%1.19%-0.83%-0.49%0.59%-2.71%-1.08%-1.64%-3.19%-1.73%-7.85%3.79%8.92%12.63%21.52%10.41%6.40%10.84%14.42%20.54%
Cost of Revenue
625.07672.79665.36652.72648.6644.07682.87642658.39658.79659.22650.55658.38648.57698.09617.81616.41577.11557.94558.71
Gross Profit
379.01323.04328.87352.13383.54340.1319.68367.77367.73352.77354.25376.07401.56380.8401.76371.35356.73336.82347.11337.23
Selling, General & Admin
214.18149.12192.02173.65185.82176.32193.23187.31165.86177.22194.33173.98197.94173.71206.09180.67127.29142.92136.2142.23
Amortization of Goodwill & Intangibles
13.0915.3592.0127.425.6829.7641.2232.428.7725.4834.0234.2334.2734.9235.4335.5337.638.0130.1932.85
Operating Expenses
227.27164.46284.04201.05211.51206.09234.46219.72194.63202.69228.35208.21232.21208.63241.53216.2164.89180.93166.39175.08
Operating Income
151.75158.5844.83151.08172.03134.0185.22148.05173.11150.08125.91167.86169.34172.18160.23155.14191.84155.89180.72162.15
Interest Expense
-30.34-26.74-23.78-25.4-29.97-27.88-28.23-30.28-32.77-35-33.54-33.74-35.04-34.38-34.78-11.38-3.7-9.43-11.55-16.46
Interest & Investment Income
1.031.031.021.421.11.41.841.533.012.21.591.371.430.810.340.120.190.130.310.14
Earnings From Equity Investments
--1.14-14.61---10.37-21.31--1.8112.13---3.28-6.71---13.9-13.14-10.3
Currency Exchange Gain (Loss)
---------------46.53--19.42-11.1-31.83-
Other Non Operating Income (Expenses)
25.99-123.1127.72-22.620.15-1.844.242.59-2.244.03-98.78-6.26-2.660.0146.56-16.62-20.36-3.6225.78-5.91
EBT Excluding Unusual Items
148.438.6235.19104.48143.3295.3241.75121.89141.11123.11107.3129.23133.06135.33119.12127.28148.54117.96150.29129.61
Merger & Restructuring Charges
-31.86-38.68-27.69-17.28-36.4-23.85-42.89-30.65-21.46-24.13.86-16.36-4.4-4.292.4-4.17-4.43-7.11-9.35-6.34
Impairment of Goodwill
---165----215-------------
Gain (Loss) on Sale of Assets
-63.40.123.38----0.66----0.96---123.41---22.7-
Asset Writedown
---139.97--35.5-35.5--------------
Other Unusual Items
----------98.5---------
Pretax Income
53.17-29.94-294.187.271.4235.98-216.7991.24119.6599.01208.71112.87128.66131.04244.92123.11144.11110.85163.64123.27
Income Tax Expense
53.93-15.14-17.8131.6418.7310.1-3.0420.9525.3924.5319.7524.8529.2227.0955.8225.533.4515.6223.8218.11
Earnings From Continuing Operations
-0.76-14.8-276.2955.5652.6925.88-213.7570.394.2674.48188.9588.0299.44103.95189.1197.61110.6695.23139.83105.16
Net Income to Company
-0.76-14.8-276.2955.5652.6925.88-213.7570.394.2674.48188.9588.0299.44103.95189.1197.61110.6695.23139.83105.16
Minority Interest in Earnings
-0.72-0.04-0.27-1.13-0.37-0.41-0.75-0.64-0.18-1.52-1.87-0.63-2.42-0.82-1.7-1.14-1.34-2.2-2.25-1.73
Net Income
-1.48-14.84-276.5654.4252.3325.47-214.569.6694.0872.96187.0887.3997.02103.13187.4196.47109.3293.02137.58103.43
Preferred Dividends & Other Adjustments
------1.20.984.095.63----------
Net Income to Common
-1.48-14.84-276.5654.4252.3325.47-215.768.6889.9967.33187.0887.3997.02103.13187.4196.47109.3293.02137.58103.43
Net Income Growth (YoY)
----20.76%-41.85%-62.17%--21.41%-7.25%-34.72%-0.17%-9.42%-11.25%10.87%36.22%-6.72%23.60%51.18%-3.92%0.50%
Shares Outstanding (Basic)
4849494949515151525151515151515151515050
Shares Outstanding (Diluted)
4849494949515152525252525151515151515252
Shares Change (YoY)
-2.63%-3.74%-3.76%-4.18%-4.88%-1.78%-0.94%-0.05%0.74%0.67%0.48%0.63%0.36%0.20%-0.34%-0.53%-0.10%0.49%1.03%1.69%
EPS (Basic)
-0.03-0.30-5.621.111.060.50-4.221.341.751.313.651.701.892.023.681.902.151.842.732.05
EPS (Diluted)
-0.03-0.30-5.621.101.060.50-4.221.331.741.303.621.691.892.013.651.882.131.812.672.01
EPS Growth (YoY)
----17.29%-39.08%-61.53%--21.30%-7.94%-35.34%-0.64%-10.11%-11.27%11.05%36.60%-6.47%23.84%50.83%-4.92%-0.98%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jul '23 Apr '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
148.62-14.8358.57178.25169.31112.3783.75213.07154.0550.74142.62139.580.742.51145.7360.3966.6222.17130.48119.19
Free Cash Flow Per Share
3.10-0.301.193.613.432.211.644.132.970.982.762.701.570.052.841.181.300.432.532.31
Gross Margin
37.75%32.44%33.08%35.04%37.16%34.56%31.89%36.42%35.84%34.87%34.95%36.63%37.89%36.99%36.53%37.54%36.66%36.85%38.35%37.64%
Operating Margin
15.11%15.92%4.51%15.04%16.67%13.62%8.50%14.66%16.87%14.84%12.42%16.35%15.98%16.73%14.57%15.68%19.71%17.06%19.97%18.10%
Profit Margin
-0.15%-1.49%-27.82%5.42%5.07%2.59%-21.52%6.80%8.77%6.66%18.46%8.51%9.15%10.02%17.04%9.75%11.23%10.18%15.20%11.54%
Free Cash Flow Margin
14.80%-1.49%5.89%17.74%16.40%11.42%8.35%21.10%15.01%5.02%14.07%13.59%7.62%0.24%13.25%6.11%6.85%2.43%14.42%13.30%
EBITDA
217.54225.73169.61236.25251.84212.68150.23236.25259.19235.43206.42246.73247.02249.25237.78229.75268.26231.19247.96230.83
EBITDA Margin
21.66%22.67%17.06%23.51%24.40%21.61%14.98%23.40%25.26%23.27%20.37%24.03%23.30%24.21%21.62%23.23%27.57%25.30%27.40%25.76%
D&A For EBITDA
65.7967.15124.7885.1679.8178.666588.286.0885.3680.5178.8777.6777.0777.5574.6176.4275.367.2468.69
EBIT
151.75158.5844.83151.08172.03134.0185.22148.05173.11150.08125.91167.86169.34172.18160.23155.14191.84155.89180.72162.15
EBIT Margin
15.11%15.92%4.51%15.04%16.67%13.62%8.50%14.66%16.87%14.84%12.42%16.35%15.98%16.73%14.57%15.68%19.71%17.06%19.97%18.10%
Effective Tax Rate
101.43%--36.29%26.22%28.07%-22.96%21.22%24.77%9.46%22.02%22.71%20.67%22.79%20.71%23.21%14.09%14.55%14.69%
Revenue as Reported
1,004995.83994.231,0051,032984.171,0031,0101,0261,0121,0131,0271,0601,0291,100989.16973.13913.93905.05895.94
SEC Filings: 10-K · 10-Q